Search by Drug Name or NDC
NDC 67457-0251-02 Dexmedetomidine 100 ug/mL Details
Dexmedetomidine 100 ug/mL
Dexmedetomidine is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is DEXMEDETOMIDINE HYDROCHLORIDE.
Product Information
| NDC | 67457-0251 |
|---|---|
| Product ID | 67457-251_b10e25f7-8d56-4c7c-b8c0-6ed0aba9d260 |
| Associated GPIs | 60206030102020 |
| GCN Sequence Number | 044671 |
| GCN Sequence Number Description | dexmedetomidine HCl VIAL 200MCG/2ML INTRAVEN |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 42360 |
| HICL Sequence Number | 020971 |
| HICL Sequence Number Description | DEXMEDETOMIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Dexmedetomidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dexmedetomidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | ug/mL |
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Labeler Name | Mylan Institutional LLC |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202881 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 67457-0251-02 (67457025102)
| NDC Package Code | 67457-251-02 |
|---|---|
| Billing NDC | 67457025102 |
| Package | 25 VIAL, GLASS in 1 CARTON (67457-251-02) / 2 mL in 1 VIAL, GLASS (67457-251-00) |
| Marketing Start Date | 2014-08-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |